Updated:
Beijing Cuihu Investment Management
Zhang Ling's Beijing-based venture firm co-invests in Chinese biotech startups alongside Sequoia China and Qiming Venture Partners.
Beijing Cuihu Investment Management
Beijing Cuihu Investment Management operates from Beijing as a venture capital firm focused on early-stage and expansion-stage investments. Founder Zhang Ling holds a controlling 60 percent ownership stake. The firm's investment activity concentrates on China's biomedical and healthcare sectors. The firm deploys capital across seed, start-up, and late-stage venture rounds. Confirmed co-investments include Beijing Zhitai Biomedical alongside Sequoia China, Qiming Venture Partners, and BlueRun Ventures. The firm also participated in funding QL Biopharm alongside Sequoia China. The portfolio is concentrated in mainland China-based biotech and pharmaceutical companies. Shareholders include Wei Tuo with a 30 percent stake and Xue Yanxiang, who serves as Legal Representative. The firm maintains a lean structure typical of specialized China-focused venture managers, with no disclosed additional offices beyond its Beijing headquarters. No recent operational events in the last 24 months are verifiable from public sources. The firm's structural differentiator is its role as a specialized co-investor alongside top-tier China venture franchises in the competitive biomedical space. By concentrating exclusively on healthcare and life sciences in a single geography, Zhang Ling's vehicle functions as a targeted access point for limited partners seeking exposure to China's drug development ecosystem without committing to larger multi-sector funds.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Principals
Zhang Ling
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Beijing Cuihu Investment Management?
Founder Zhang Ling controls 60 percent of the firm and leads investment decisions. Wei Tuo, a business partner, holds a 30 percent ownership stake. Xue Yanxiang serves as the firm's Legal Representative.
Which sectors does Beijing Cuihu Investment Management target?
The firm concentrates on biomedical and healthcare companies in China. Known portfolio companies include Beijing Zhitai Biomedical and QL Biopharm, both drug developers. The firm does not publicly disclose investments outside the healthcare sector.
Does Beijing Cuihu Investment Management co-invest with other firms?
Yes. The firm has co-invested with Sequoia China in both Beijing Zhitai Biomedical and QL Biopharm. In Beijing Zhitai Biomedical, additional co-investors included Qiming Venture Partners and BlueRun Ventures.
What investment stages does Beijing Cuihu Investment Management target?
The firm participates in seed, start-up, and expansion or late-stage venture rounds. Its strategy spans the full venture lifecycle within its biomedical focus, from initial formation through later growth capital.
Is Beijing Cuihu Investment Management a single-family office or a venture firm?
It operates as a venture capital asset manager, not a family office. Founder Zhang Ling controls the firm through a majority equity stake, with outside minority shareholders Wei Tuo and Xue Yanxiang also holding ownership positions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: